Press-release for stocks for OCX

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Published: 2024-04-11 (Crawled : 21:00) - globenewswire.com
BIO | News | $279.73 -0.46% 0.0% 290K

| -16.32% | O: -5.2% H: 0.24% C: -2.79%
OCX J | $2.495 -2.54% -2.61% 50K

| -12.65% | O: 7.93% H: 3.12% C: -15.31%
assay global

Biopharma Layoff Tracker 2023: Selecta Biosciences, Zymergen, Transplant Genomics and More Cut Staff
Published: 2023-05-05 (Crawled : 21:00) - biospace.com/
VXRT | $0.7652 -9.15% -10.08% 1.9M

| 1.16% | O: -6.98% H: 12.49% C: 9.22%
TXMD | $1.86 -1.59% -1.61% 10K

| -53.33% | O: -0.25% H: 2.02% C: -5.2%
NKTR | $1.265 -4.17% -4.35% 4.7M

| 70.39% | O: -0.29% H: 6.84% C: 3.62%
MOR | $17.96 -0.5% -0.5% 180K

| 224.64% | O: 0.72% H: 2.32% C: 0.54%
GOOGL | News S | $154.08 -1.24% -1.25% 32M

| 48.35% | O: 0.12% H: 1.01% C: 0.72%
GOOG | News S | $155.7 -1.12% -1.13% 20M

| 49.14% | O: 0.1% H: 1.06% C: 0.85%
OCX J | $2.495 -2.54% -2.61% 50K

| 865.7% | O: -1.75% H: 2.09% C: -0.87%
genomics biopharma

Oncocyte Reports First Quarter 2022 Financial Results
Published: 2022-05-11 (Crawled : 21:00) - biospace.com/
OCX J | $2.495 -2.54% -2.61% 50K

| 123.28% | O: -2.59% H: 2.65% C: 0.0%
results

10 unverzeihliche Sünden von nebenwirkungen steroide bei frauen
Published: 2021-12-06 (Crawled : 21:00) - oncocyte.com
OCX J | $2.495 -2.54% -2.61% 50K

| 10.21% | O: 0.85% H: 5.49% C: 1.27%

Wie Sie Ihr steroide richtig anwenden wie eine Million Dollar aussehen lassen
Published: 2021-12-06 (Crawled : 21:00) - oncocyte.com
OCX J | $2.495 -2.54% -2.61% 50K

| 10.21% | O: 0.85% H: 5.49% C: 1.27%